Frederiksen, C <br/><br/>
Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Feb 2011 
 - 369-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdq354  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Capecitabine<br/>Colorectal Neoplasms--drug therapy<br/>Deoxycytidine--analogs & derivatives<br/>Female<br/>Fluorouracil--analogs & derivatives<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Oxaloacetates<br/>Survival Analysis<br/>Tissue Inhibitor of Metalloproteinase-1--blood<br/>Treatment Outcome